Stay updated on Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedCurrently, the page shows a new Revision: v3.3.2 replacing v3.3.1, which appears to be a metadata update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedA PubMed auto-fill publication note was added and the revision tag was updated to v3.3.1; these edits do not modify core study content, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedA new publication citation for Lebrikizumab (Clin Exp Dermatol, 2025) was added to the Publications section. A government funding lapse notice was removed from the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedNo additions or deletions detected on the page for NCT04178967. The study details and layout remain unchanged.SummaryDifference0.2%

- Check76 days agoChange DetectedPage updated to Revision: v3.2.0 from Revision: v3.0.2; indicates a new release version with no other substantive content changes.SummaryDifference0.0%

- Check83 days agoChange DetectedRemoved several core sections on drug safety and quality (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).SummaryDifference0.1%

Stay in the know with updates to Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.